Stories about Medikament

STADA Arzneimittel AG

Press Release: STADA obtains approvals to bring denosumab biosimilars in bone-health and oncology to patients in Europe

STADA obtains approvals to bring denosumab biosimilars in bone-health and oncology to patients in Europe - European Commission approves STADA’s Kefdensis® and Zvogra® denosumab biosimilars for all indications of reference medicines Prolia® and ...

Asklepios Kliniken GmbH & Co. KGaA

Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award

Wiesbaden, Germany (ots) - - Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy - One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time - Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical ...

LTS Lohmann Therapie-Systeme AG

LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood

Andernach (ots) - LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading pharmaceutical technology company today announces the acquisition of Renaissance Lakewood, LLC (“Renaissance”), a US-based contract development and manufacturing organization (CDMO) specializing in nasal sprays and sterile dosage forms. With the acquisition, Renaissance facilities will become ...

Vaccentis AG

Letter of Intent for strategic partnership / Vaccentis and TrueMed join forces to advance cancer vaccine

Zurich (ots) - Vaccentis, a Zurich based biotech company specializing in the development of therapeutic protein-based tumor vaccines, has signed a letter of intent with TrueMed, a leading commercialization partner. Accelerating cancer vaccine against renal cell carcinoma The aim of this letter of intent is to ...

PNO Innovation GmbH

MaP Toolbox: Your Hub for Master Protocol Clinical Trials

Asklepios Kliniken GmbH & Co. KGaA

2

Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 2025

Europäischer Rechnungshof - European Court of Auditors

Niedobory leków w UE wciąż przyprawiają o ból głowy

Europäischer Rechnungshof - European Court of Auditors

Läkemedelsbristen är fortfarande en kronisk huvudvärk för EU

Europäischer Rechnungshof - European Court of Auditors

Lääkepula yhä EU:n päänsärkynä

Europäischer Rechnungshof - European Court of Auditors

Medicine shortages still a chronic headache for the EU

Europäischer Rechnungshof - European Court of Auditors

Medicinmangler er en hovedpine for EU

Europäischer Rechnungshof - European Court of Auditors

(Presskonferens) Kan EU bota bristen på kritiska läkemedel?

Kan EU bota bristen på kritiska läkemedel? - Presskonferens online onsdagen den 17 september kl. 10.00 CEST. - Offentliggörande samma dag kl. 17.00 CEST. Europeiska revisionsrätten inbjuder härmed till en presskonferens online inför offentliggörandet av en särskild rapport om EU:s åtgärder för att säkerställa ...

Europäischer Rechnungshof - European Court of Auditors

(Ενημέρωση Τύπου) Μπορεί η ΕΕ να θεραπεύσει τις ελλείψεις σε φάρμακα κρίσιμης σημασίας;

Μπορεί η ΕΕ να θεραπεύσει τις ελλείψεις σε φάρμακα κρίσιμης σημασίας; - Διαδικτυακή ενημέρωση Τύπου: Τετάρτη 17 Σεπτεμβρίου, ...

Europäischer Rechnungshof - European Court of Auditors

(Tiedotustilaisuus) Voiko EU löytää parannuskeinon lääkepulaan?

Voiko EU löytää parannuskeinon lääkepulaan? - Tiedotustilaisuus verkossa keskiviikkona 17. syyskuuta klo 10.00 Keski-Euroopan kesäaikaa - Kertomus julkaistaan samana päivänä klo 17.00 Keski-Euroopan kesäaikaa Euroopan tilintarkastustuomioistuin kutsuu teidät ...

Europäischer Rechnungshof - European Court of Auditors

(Pressebriefing) Kan EU afhjælpe kritiske mangler på lægemidler?

Kan EU afhjælpe kritiske mangler på lægemidler? - Online pressebriefing: onsdag den 17. september kl. 10.00 CEST - Offentliggørelse: samme dag kl. 17.00 CEST Den Europæiske Revisionsret inviterer til online pressebriefing vedrørende sin kommende særberetning om EU's foranstaltninger til at sikre tilgængelighed af lægemidler ...

Europäischer Rechnungshof - European Court of Auditors

(Press briefing) Can the EU cure critical medicine shortages?

Can the EU cure critical medicine shortages? - Online press briefing: Wednesday 17 September at 10.00 a.m. CEST - Publication: Same day at 5.00 p.m. CEST The European Court of Auditors (ECA) would like to invite you to an online press briefing on its upcoming special report on EU measures to ensure the availability of medicines – ...

Europäischer Rechnungshof - European Court of Auditors

(Spotkanie informacyjne) Czy UE rozwiąże problem krytycznych niedoborów leków?

Czy UE rozwiąże problem krytycznych niedoborów leków? - Spotkanie informacyjne online – środa 17 września o godz. 10.00 CEST - Publikacja – tego samego dnia o godz. 17.00 Europejski Trybunał Obrachunkowy serdecznie zaprasza na spotkanie informacyjne online dla prasy ...

DHL Group

PM: DHL übernimmt SDS Rx und stärkt damit seine Kompetenzen im Bereich Life Sciences und Healthcare / PR: DHL Agrees to Acquire SDS Rx Expanding Its Life Sciences and Healthcare Capabilities

Asklepios Kliniken GmbH & Co. KGaA

Nominations for the Broermann Medical Innovation Award 2026 now open

Hamburg (ots) - - With a million euros, it is one of the world’s most highly endowed awards for medical research The nomination period for the Broermann Medical Innovation Award 2026 has begun. Endowed with a million euros, this international award is among the most prestigious honors for medical research worldwide. Scientists from around the globe who have made ...

Grünenthal Group

Grünenthal PRO is joining SHL Medical’s alliance partnership network to offer final assembly service for Molly® autoinjectors

Aachen (ots) - Grünenthal PRO, the contract development and manufacturing organization (CDMO) division of Grünenthal offering a range of services including final assembly of autoinjectors, is entering into a non-exclusive partnership with SHL Medical, a world-leading solutions provider of advanced drug delivery ...

D4L data4life gGmbH

Data4Life announces the appointment of Dr. Ben Illigens as new CEO by the Hasso Plattner Foundation

UCB

UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

Brussels (ots/PRNewswire) - - 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies - Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning ...

STADA Arzneimittel AG

Press release: Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. Press release ...

Helmholtz Munich

2

New Endoscopy Technology Enables Early Detection of Esophageal Cancer